Literature DB >> 25345602

Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction.

Tosan Ehanire1, Licheng Ren, Jennifer Bond, Manuel Medina, George Li, Latif Bashirov, Lei Chen, George Kokosis, Mohamed Ibrahim, Angelica Selim, Gerard C Blobe, Howard Levinson.   

Abstract

UNLABELLED: Hypertrophic scar contraction (HSc) is caused by granulation tissue contraction propagated by myofibroblast and fibroblast migration and contractility. Identifying the stimulants that promote migration and contractility is key to mitigating HSc. Angiotensin II (AngII) promotes migration and contractility of heart, liver, and lung fibroblasts; thus, we investigated the mechanisms of AngII in HSc. Human scar and unwounded dermis were immunostained for AngII receptors angiotensin type 1 receptor (AT1 receptor) and angiotensin type 2 receptor (AT2 receptor) and analyzed for AT1 receptor expression using Western blot. In vitro assays of fibroblast contraction and migration under AngII stimulation were conducted with AT1 receptor, AT2 receptor, p38, Jun N-terminal kinase (JNK), MEK, and activin receptor-like kinase 5 (ALK5) antagonism. Excisional wounds were created on AT1 receptor KO and wild-type (WT) mice treated with AngII ± losartan and ALK5 and JNK inhibitors SB-431542 and SP-600125, respectively. Granulation tissue contraction was quantified, and wounds were analyzed by immunohistochemistry. AT1 receptor expression was increased in scar, but not unwounded tissue. AngII induced fibroblast contraction and migration through AT1 receptor. Cell migration was inhibited by ALK5 and JNK, but not p38 or MEK blockade. In vivo experiments determined that absence of AT1 receptor and chemical AT1 receptor antagonism diminished granulation tissue contraction while AngII stimulated wound contraction. AngII granulation tissue contraction was diminished by ALK5 inhibition, but not JNK. AngII promotes granulation tissue contraction through AT1 receptor and downstream canonical transforming growth factor (TGF)-β signaling pathway, ALK5. Further understanding the pathogenesis of HSc as an integrated signaling mechanism could improve our approach to establishing effective therapeutic interventions. KEY MESSAGE: AT1 receptor expression is increased in scar tissue compared to unwounded tissue. AngII stimulates expression of proteins that confer cell migration and contraction. AngII stimulates fibroblast migration and contraction through AT1 receptor, ALK5, and JNK. AngII-stimulated in vivo granulation tissue contraction is AT1 receptor and ALK5 dependent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25345602      PMCID: PMC4334749          DOI: 10.1007/s00109-014-1211-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  34 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  Effects of angiotensin II receptor signaling during skin wound healing.

Authors:  Hikaru Takeda; Yohtaro Katagata; Yutaka Hozumi; Shigeo Kondo
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Scar treatments: preclinical and clinical studies.

Authors:  Richard G Reish; Elof Eriksson
Journal:  J Am Coll Surg       Date:  2008-01-28       Impact factor: 6.113

4.  Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.

Authors:  Li Li; Dong Fan; Cheng Wang; Jin-Yu Wang; Xiao-Bing Cui; Dan Wu; Yun Zhou; Li-Ling Wu
Journal:  Cardiovasc Res       Date:  2011-03-02       Impact factor: 10.787

5.  Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression.

Authors:  Jennifer E Bond; Andrew Bergeron; Peter Thurlow; M Angelica Selim; Edith V Bowers; Anna Kuang; Howard Levinson
Journal:  Mol Med       Date:  2011-07-21       Impact factor: 6.354

6.  Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.

Authors:  R Wang; A Ghahary; Q Shen; P G Scott; K Roy; E E Tredget
Journal:  Wound Repair Regen       Date:  2000 Mar-Apr       Impact factor: 3.617

7.  Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model.

Authors:  Hakan Uzun; Ozan Bitik; Rümeysa Hekimoğlu; Pergin Atilla; Aycan Uğur Kaykçoğlu
Journal:  Plast Reconstr Surg       Date:  2013-09       Impact factor: 4.730

8.  The molecular mechanism of hypertrophic scar.

Authors:  Zhensen Zhu; Jie Ding; Heather A Shankowsky; Edward E Tredget
Journal:  J Cell Commun Signal       Date:  2013-03-18       Impact factor: 5.782

9.  JunB mediates basal- and TGFβ1-induced smooth muscle cell contractility.

Authors:  Aruna Ramachandran; Samudra S Gangopadhyay; Ramaswamy Krishnan; Sandeep A Ranpura; Kavitha Rajendran; Sumati Ram-Mohan; Michelle Mulone; Edward M Gong; Rosalyn M Adam
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

10.  Involvement of mast cell chymase in burn wound healing in hamsters.

Authors:  Xianglin Dong; Zhongli Geng; Yang Zhao; Junjie Chen; Ying Cen
Journal:  Exp Ther Med       Date:  2012-11-27       Impact factor: 2.447

View more
  10 in total

1.  Moxibustion Promotes Formation of Granulation in Wound Healing Process through Induction of Transforming Growth Factor-β in Rats.

Authors:  Hiroshi Kawanami; Hirohisa Kawahata; Hiroko-Miyuki Mori; Motokuni Aoki
Journal:  Chin J Integr Med       Date:  2019-11-28       Impact factor: 1.978

Review 2.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

3.  Early intervention by Captopril does not improve wound healing of partial thickness burn wounds in a rat model.

Authors:  Johanneke J J Akershoek; Katrien M Brouwer; Marcel Vlig; Bouke K H L Boekema; Rob H J Beelen; Esther Middelkoop; Magda M W Ulrich
Journal:  Burns       Date:  2017-10-09       Impact factor: 2.744

4.  Stem Cells in Keloid Lesions: A Review.

Authors:  Kim H Lim; Tinte Itinteang; Paul F Davis; Swee T Tan
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

Review 5.  Functional Relevancies of Trans-Differentiation in the Juxtaglomerular Apparatus of Rat Kidney.

Authors:  Zsolt Razga
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-06-12

6.  Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection.

Authors:  Jorge Quarleri; Cintia Cevallos; M Victoria Delpino
Journal:  Immunol Lett       Date:  2021-02-10       Impact factor: 3.685

Review 7.  Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma.

Authors:  Ryan G Strickland; Mary Anne Garner; Alecia K Gross; Christopher A Girkin
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

8.  Lithium Treatment Improves Cardiac Dysfunction in Rats Deprived of Rapid Eye Movement Sleep.

Authors:  Pao-Huan Chen; Cheng-Chih Chung; Shuen-Hsin Liu; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

9.  Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer.

Authors:  Lauren T Maloney; Emile Latour; Yiyi Chen; Douglas Rice; Alison Grossblatt-Wait; Nima Nabavizadeh; Charles R Thomas; Kristina H Young; Joshua M Walker; John Holland; Aaron J Grossberg
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

10.  Wound healing potential of lavender oil by acceleration of granulation and wound contraction through induction of TGF-β in a rat model.

Authors:  Hiroko-Miyuki Mori; Hiroshi Kawanami; Hirohisa Kawahata; Motokuni Aoki
Journal:  BMC Complement Altern Med       Date:  2016-05-26       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.